HOXA9 and leukemia: Three out of five mice transplanted with Hoxa9 cells developed late onset leukemia, with the first mice progressing into leukemia displaying disease symptoms, as determined by increased white blood cell counts along with an increased frequency of GFP+/YFP+ leukemic cells in blood, approximately 16 weeks after transplantation (Fig. 2g).